Electrical engineers, computer scientists and biomedical engineers at the University of California, Irvine have created a new lab-on-a-chip that can help study tumor heterogeneity to reduce resistance to cancer therapies. … "Cancer cell and tumor heterogeneity can lead to increased therapeutic resistance and inconsistent outcomes for different patients," said lead author Kushal Joshi, a former UCI graduate student in biomedical engineering. The team's novel biochip addresses this problem by allowing precise characterization of a variety of cancer cells from a sample. Read More